Dual effect of advanced glycation end products in pancreatic islet apoptosis

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 4, 2013, Pages 296-307

  Costal, Flavia ^a   Oliveira, Erika ^a   Raposo, Alexandre ^a   Machado Lima, Adriana ^a   Peixoto, Elisa ^b   Roma, Letícia ^a   Santos, Laila ^a   Lopes Faria, José B ^b   Carpinelli, Angelo Rafael ^a   Giannella Neto, Daniel ^c   Passarelli, Marisa ^a   Correa Giannella, Maria Lucia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Advanced glycation end products (AGEs); Apoptosis; Oxidative stress; Pancreatic islets

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA; SUPEROXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT;

ALBUMINS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; ISLETS OF LANGERHANS; LUMINESCENCE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NADPH OXIDASE; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDES;

EID: 84877319932     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2390     Document Type: Article

References (35)

1. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104(6): 787-794.
2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46(1): 3-19.
3. Leonardi O, Mints G, Hussain MA. Beta-cell apoptosis in the pathogenesis of human type 2 diabetes mellitus. Eur J Endocrinol 2003; 149(2): 99-102.
4. Shanmugam N, Todorov I, Nair I, Omori K, Reddy M, Natarajan R. Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice. Diabetologia 2006; 49(1): 100-107.
5. Kaneto H, Fujii J, Myint T, et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 1996; 320(Pt 3): 855-863.
6. Lim M, Park L, Shin G, Hong H, Kang I, Park Y. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Ann N Y Acad Sci 2008; 1150: 311-315.
7. Shu T, Zhu Y, Wang H, Lin Y, Ma Z, Han X. AGEs decrease insulin synthesis in pancreatic β-cell by repressing Pdx-1 protein expression at the post-translational level. PLoS One 2011; 6(4): e18782.
8. Zhao Z, Zhao C, Zhang XH, et al. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology 2009; 150(6): 2569-2576.
9. Jung H, Joo J, Jeon Y, et al. Advanced glycation end products downregulate glucokinase in mice. Diabetes Metab Res Rev 2011; 27(6): 557-563.
10. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002; 251(2): 87-101.
11. Degenhardt TP, Thorpe SR, Baynes JW. Chemical modification of proteins by methylglyoxal. Cell Mol Biol (Noisy-le-Grand) 1998; 44(7): 1139-1145.
12. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995; 34(11): 3702-3709.
13. Thornalley PJ. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 1990; 269(1): 1-11.
14. Lin L. RAGE on the Toll Road? Cell Mol Immunol 2006; 3(5): 351-358.
15. Huebschmann A, Regensteiner J, Vlassara H, Reusch J. Diabetes and advanced glycoxidation end products. Diabetes Care 2006; 29(6): 1420-1432.
16. Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001; 27(5 Pt 1): 535-542.
17. Kislinger T, Fu C, Huber B, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999; 274(44): 31740-31749.
18. San Martin A, Foncea R, Laurindo FR, Ebensperger R, Griendling KK, Leighton F. Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products. Free Radic Biol Med 2007; 42(11): 1671-1679.
19. Wautier M, Chappey O, Corda S, Stern D, Schmidt A, Wautier J. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280(5): E685-694.
20. Machado AP, Pinto RS, Moysés ZP, Nakandakare ER, Quintão EC, Passarelli M. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. Int J Biochem Cell Biol 2006; 38(3): 392-403.
21. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 1997; 411(1): 77-82.
22. Avci{dotless} CB, Gündüz C, Baran Y, et al. Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells. J Cancer Res Clin Oncol 2011; 137(1): 41-47.
23. Bardag-Gorce F, French BA, Nan L, et al. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 2006; 81(3): 191-201.
24. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 2009; 29(4): 309-318.
25. Corbisier P, Houbion A, Remacle J. A new technique for highly sensitive detection of superoxide dismutase activity by chemiluminescence. Anal Biochem 1987; 164(1): 240-247.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
27. Sun QA, Hess DT, Wang B, Miyagi M, Stamler JS. Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1, 2, 3-triazolo[4, 5-d]pyrimidine (VAS2870). Free Radic Biol Med 2012; 52(9): 1897-1902.
28. ten Freyhaus H, Huntgeburth M, Wingler K, et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 2006; 71(2): 331-341.
29. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29(9): e45.
30. Yin X, Oltvai Z, Veis-Novack D, Linette G, Korsmeyer S. Bcl-2 gene family and the regulation of programmed cell death. Cold Spring Harb Symp Quant Biol 1994; 59: 387-393.
31. Ramasamy R, Vannucci S, Yan S, Herold K, Yan S, Schmidt A. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005; 15(7): 16R-28R.
32. Zhu Y, Shu T, Lin Y, et al. Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells. Biochem Biophys Res Commun 2011; 404(1): 159-165.
33. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008; 57(6): 1446-1454.
34. Lin N, Zhang H, Su Q. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress. Diabetes Metab 2012; 38(3): 250-257.
35. Lee BW, Chae HY, Kwon SJ, Park SY, Ihm J, Ihm SH. RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress. Int J Mol Med 2010; 26(6): 813-818.